CLINICAL_TRIALS
trial_result
· 2020-08-13
Clinical Trial Update: The Effects of BAY1193397 on Skin Capillary Blood Flow and Transcutaneous Oxygen Pressure [Phase 2]
Summary
Phase 2 trial update investigating BAY1193397 effects on skin capillary blood flow and transcutaneous oxygen pressure in diabetic foot patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Diabetic Foot | Phase 2 | Status: COMPLETED